Literature DB >> 11818895

The impact of Medicaid-linked reimbursements on revenues of public sexually transmitted disease clinics.

Lois Downey1, William E Lafferty, Barbara Krekeler.   

Abstract

BACKGROUND: Public sexually transmitted disease (STD) clinics faced with decreased tax revenue and increased costs must evaluate alternative revenue sources. GOAL: To report one public STD clinic's Medicaid-linked revenue and discuss the association between system characteristics and reimbursement potential.
DESIGN: This was a cross-sectional study of 4208 patients visiting the clinic for new problems during a 6-month period.
RESULTS: Of 458 Medicaid-enrolled patients, only 55% acknowledged enrollment at the time of visit. The clinic captured revenue for many of the remaining 45% through a centralized public health information/billing system, which submitted retroactive STD clinic claims when patients self-reported Medicaid enrollment at later visits to other public health clinics. These belated self-reports also contributed to Medicaid administrative-match reimbursements.
CONCLUSIONS: An estimated $100,000 (31% of the clinic's direct reimbursements for service) would have been lost in 2000, had detection of Medicaid enrollment been based exclusively on patients' self-reports at STD clinic visits.

Entities:  

Mesh:

Year:  2002        PMID: 11818895     DOI: 10.1097/00007435-200202000-00006

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  2 in total

1.  Medicaid Coverage of Sexually Transmitted Disease Service Visits.

Authors:  William S Pearson; Ian H Spicknall; Ryan Cramer; Wiley D Jenkins
Journal:  Am J Prev Med       Date:  2019-05-22       Impact factor: 5.043

2.  HIV Testing and HIV Service Delivery to Populations at High Risk Attending Sexually Transmitted Disease Clinics in the United States, 2011-2013.

Authors:  Puja Seth; Guoshen Wang; Erin Sizemore; Matthew Hogben
Journal:  Am J Public Health       Date:  2015-09-17       Impact factor: 9.308

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.